Elite Pharmaceuticals Inc (ELTP) income statement
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –
Elite Pharmaceuticals Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 43.5%
- Operating margin
- 24.8%
- Net margin
- 40.2%
- Return on equity, FY2026
- 58.9%
Financial strength
- Current ratio
- 3.76
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 127.9%
Valuation
- P/E ratio
- 5.0
- Price to sales
- 2.01
- Price to book
- 2.70
- Dividend yield
- –
See a number that looks wrong?